2001
DOI: 10.1053/bega.2001.0230
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology of NSAID-related gastroduodenal mucosal injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
32
0

Year Published

2002
2002
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(34 citation statements)
references
References 79 publications
2
32
0
Order By: Relevance
“…The study presented here was in accordance with the study of Aalykke [18] who found that the incidence of dyspepsia as a gastro intestinal side effect was strongly correlated with the duration of administration of Ibuprofen.…”
Section: Discussionsupporting
confidence: 92%
“…The study presented here was in accordance with the study of Aalykke [18] who found that the incidence of dyspepsia as a gastro intestinal side effect was strongly correlated with the duration of administration of Ibuprofen.…”
Section: Discussionsupporting
confidence: 92%
“…Besides personal risk factors, the type and the dose of NSAIDs, duration of exposure to the drug and concomitant use of other drugs play an important role on NSAID-related GI side effects [11] . In our study, we observed a positive correlation between endoscopically observed gastric injury and age, although none of our patients were in the age group (> 60 years) established as an individual risk factor.…”
Section: Discussionmentioning
confidence: 99%
“…Intramucosal hemorrhage, petechia, and mucosal erosions have been observed endoscopically with shortterm usage. Superficial ulceration typically appears within 1 wk [11] . Following single-dose (650-1300 mg) aspirin intake, gastric lesions occur with a 100% certainty [12] .…”
Section: Discussionmentioning
confidence: 99%
“…Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used to relieve pain in such patients. Because of the untoward effect of non-selective NSAIDs on the upper gastrointestinal tract, mainly among the elderly population, 1 there is a trend to use NSAIDs of newer generation such as highly selective cyclooxygenase-2 (COX-2) inhibitors. These new COX-2 inhibitors (rofecoxib and celecoxib) mainly inhibit 'inducible' cyclooxygenase at the site of the inflammation, and do not influence 'constitutional' cyclooxygenase.…”
Section: Introductionmentioning
confidence: 99%